ARCHIVES

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

This article is from The Cancer Letter archive.

Vol. 14 No. 15 | April 8, 1988

Download PDF Visit The Full Archive

Related Articles

New Subcommittee Chairman Named

June 10, 1977

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Enck New ACCC President, King President Elect

March 20, 1987

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

More Radiation Increases Prostate Cancer Response

August 30, 2002